Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.
about
Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile functionHydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxationMolecular pathophysiology of priapism: emerging targetsY-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosumEvidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile functionY-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the Rho-kinase pathwaysRhoA-mediated Ca2+ sensitization in erectile function.Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injuryReflex vasoconstriction in aged human skin increasingly relies on Rho kinase-dependent mechanisms during whole body coolingUp-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.Molecular targets for diabetes mellitus-associated erectile dysfunction.Future prospects in the treatment of erectile dysfunction: focus on avanafil.A comprehensive review of urologic complications in patients with diabetes.RhoA/Rho-kinase and vascular diseases: what is the link?Current treatments and emerging therapeutic approaches in male erectile dysfunction.Erectile function is improved in aged rats by PnTx2-6, a toxin from Phoneutria nigriventer spider venom.RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunctionInvolvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function.Current oral treatments for erectile dysfunction.The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-2272 relax rabbit vaginal wall and clitoral corpus cavernosumThe pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.Prostatic disease and sexual dysfunctionInhibition of the tonic contraction in the treatment of erectile dysfunction.The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of rho-kinase and their potential role in the erectile response.A role for LIM kinase in cancer invasion.The future is today: emerging drugs for the treatment of erectile dysfunctionGas what: NO is not the only answer to sexual function.Current Diagnosis and Management of Erectile DysfunctionMetformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.Effects of cigarette smoking on erectile dysfunctionThe link between LUTS and ED: clinical and basic science evidence.Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis.Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.ROCKs as therapeutic targets in cardiovascular diseasesGene and stem cell therapy for erectile dysfunction.Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.Physiological role of ROCKs in the cardiovascular systemUnderstanding and targeting the Rho kinase pathway in erectile dysfunction.
P2860
Q24601756-F256578B-0636-4F93-ACCD-DF3E78971351Q24656291-C538CEBE-B3A5-4091-A383-336D8E12ED4EQ27010069-495FC6B2-29C5-4DB3-8F03-A4689EC9D505Q28366547-DE444433-ECAD-43DA-902F-4F91D5DBEECFQ28566424-38687A03-1768-403E-8CA8-3B469429C3B6Q28576020-265C754A-1117-4EFF-A773-B7A948F3E3DAQ30309468-E43C2BB8-AE64-473C-B98E-E586BCD1B0FAQ30413234-629A928F-90D1-47EA-A69C-53942AB7C4A9Q33498337-F459D6EF-DC78-45A5-98AE-3FB8A69D5698Q33755241-14272A97-D934-4BC9-9160-150B4C031D41Q33770111-BDB2790B-7F8C-46BE-A834-4A8B9246EED4Q34029414-2E822635-09B6-4CFE-A690-2DB6D8F2D002Q34283239-727B91E2-1CD4-47CD-A27C-001BD551B8FBQ34378293-1F566246-2B2F-4186-B785-3A22824164FEQ34385721-2AA0EA4A-5955-48E4-BD44-DAF1D8D5C258Q34641766-BE7E4806-7AD5-4882-B26A-9C4584C97EAAQ34836681-49053459-BAD2-4D59-ACF5-415B36425AEEQ34983511-B130E33A-22B2-4DF7-8B25-9874FED02F07Q35000972-B1D71B18-EF0A-4140-B946-93F043FBBAE4Q35044932-8ADB9137-D5AA-4FC8-BFE0-5DE8606406E2Q35055194-9BF7CFA4-91D3-40C5-B965-A07CEE072850Q35070009-DA5B7B6B-F6B0-42DF-846F-46C385B4ACC1Q35095163-11150F73-AB87-4FC5-8C7F-7E07A85FB18BQ35146603-5AF39A73-44E0-4422-B17E-65855EFC17E1Q35163454-379008D8-45DA-42D2-940C-EB769AD0C245Q35186022-9FEDB7B4-3FB7-4C25-B235-C04074CE5BC3Q35204833-D0A619AC-3320-4C18-93A4-6A2701910B46Q35384480-935B50F9-3622-471C-90C9-852124A7EEEEQ35599981-AF655296-79B0-4419-BE55-E9B1DEB9DDD3Q35765882-0A925215-3493-4AEC-9762-152CC8B9D212Q35799919-E2E4A23A-D028-401E-A47E-39E1CF36BFFCQ35821086-81C83E20-1DAF-4A03-9F0A-8FCD6CCB8E45Q35824102-D56E2BF9-DD68-4872-B898-95EDCB7254CCQ35894523-7DC053E7-3DFC-4F50-82EA-CB315B41614FQ36056143-E101C162-B32D-4A76-B890-1B039306C17BQ36124892-F54AAA71-D8FF-418F-B1E6-FA18C534A4E1Q36359862-39A3F4BF-883E-4621-9220-7B30E0045C52Q36371582-6215F60C-2521-48D2-91DF-3F81B47A4284Q36392528-A7AA10B4-67BD-4E18-B0E5-35EF89AC76E9Q36416633-78119BD2-BE2F-4215-8744-8B34EA03EAA9
P2860
Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antagonism of Rho-kinase stimu ...... ric oxide-independent pathway.
@ast
Antagonism of Rho-kinase stimu ...... ric oxide-independent pathway.
@en
type
label
Antagonism of Rho-kinase stimu ...... ric oxide-independent pathway.
@ast
Antagonism of Rho-kinase stimu ...... ric oxide-independent pathway.
@en
prefLabel
Antagonism of Rho-kinase stimu ...... ric oxide-independent pathway.
@ast
Antagonism of Rho-kinase stimu ...... ric oxide-independent pathway.
@en
P2093
P356
P1433
P1476
Antagonism of Rho-kinase stimu ...... tric oxide-independent pathway
@en
P2093
P2888
P304
P356
10.1038/83258
P407
P577
2001-01-01T00:00:00Z
P6179
1036056981